Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

PharmaCyte Biotech, Inc. (PMCB)

NASDAQ

$0.37

$-0.01

(-1.60%)

Pre-Market

PharmaCyte Biotech, Inc. (PMCB) Live Price Chart

Last updated: ⁦2026-09-16 12:10:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

PharmaCyte Biotech, Inc. (PMCB) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $0.37, with a market capitalisation of $4.21M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.33 to $1.51. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$4.21M
Open	$0.37
Day's High	$9.98
Day's Low	$0.33
Previous Close	$0.38
Volume	1.00K
Average Volume	128.34K
P/E Ratio	--
52-Week High	$1.51
52-Week Low	$0.33
Dividend Yield	8.07%
Earnings Date	--

PharmaCyte Biotech, Inc. (PMCB) Pre-Market Stock Price

PharmaCyte Biotech, Inc. (PMCB) is trading at $0.37 in pre-market trading as of 2026-09-16 11:58:00, down 3.74% ($0.01) from the previous close of $0.38

Pre-market trading shows how investors are pricing PMCB before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.

PharmaCyte Biotech, Inc. (PMCB) 7-Day Stock Price Change

Over the past seven days, PharmaCyte Biotech, Inc. (PMCB) moved from $0.49 to $0.37, representing a decline of 24.36% ($0.12).

The stock traded between $0.33 and $0.52 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 307.03 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

PMCB 52-Week Price Position

Position in Range: 2.9%

52W Low$0.33

52W High$1.51

PMCB is currently trading at $0.37, placing it 2.9% of the way from its 52-week low of $0.33 to its 52-week high of $1.51. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is PharmaCyte Biotech, Inc. (PMCB)?

PharmaCyte Biotech Inc is a biotechnology company focused on developing cellular therapies for cancer based on its proprietary cellulose-based live cell encapsulation technology, Cell-in-a-Box. The technology is intended to be used as a platform for therapies for several types of cancer, including locally advanced, inoperable pancreatic cancer (LAPC). The current generation of the Company's product candidate is CypCaps. The Company is preparing to commercialize cellular therapies for cancer and advance clinical research and development, including a clinical trial in LAPC using encapsulated live cells. Its candidate therapy involves encapsulating genetically engineered human cells that convert an inactive chemotherapy drug into its active, cancer-killing form.

PharmaCyte Biotech, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	2
Exchange	NASDAQ
Company Website	https://pharmacyte.com

How to Buy PharmaCyte Biotech, Inc. (PMCB) Stock on MEXC

Eligible investors can buy real shares of PharmaCyte Biotech, Inc. (PMCB) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for PMCB and Place Your Order

Open the RealStocks trading page and search for PMCB. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is PharmaCyte Biotech, Inc. (PMCB) stock price today?

PharmaCyte Biotech, Inc. (PMCB) is currently trading at $ 0.37, down 3.74% ($0.01) from the previous close of $ 0.38. Intraday prices update in real time during regular trading hours.

2.Is PMCB stock going up or down today?

As of 2026-09-16 11:58:00, PMCB is trading at $ 0.37, down 3.74% ($0.01) from its previous close of $ 0.38. The stock has traded between $ 0.33 and $ 9.98 during today’s regular session. Past price movements do not guarantee future results.

3.What is PMCB pre-market price?

As of 2026-09-16 11:58:00, PMCB is trading at $ 0.37 in pre-market trading, down 3.74% ($0.01) from the previous close of $ 0.38. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is PMCB after-hours price?

As of 2026-09-16 11:58:00, PMCB is trading at $ 0.38 in after-hours trading, down 1.91% ($0.01) from the regular-session close of $ 0.38. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is PMCB stock trading now?

PMCB trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does PMCB sit relative to its 52-week high and low?

Over the past 52 weeks, PMCB has traded between a low of $ 0.33 and a high of $ 1.51. At $ 0.37, the stock is positioned 2.9% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is PharmaCyte Biotech, Inc. in?

PharmaCyte Biotech, Inc. (PMCB) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is PharmaCyte Biotech, Inc.'s market capitalisation and where is it listed?

PharmaCyte Biotech, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 4.21M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is PMCB valued in terms of P/E ratio and EPS?

PMCB trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -3.35. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does PharmaCyte Biotech, Inc. pay a dividend?

PharmaCyte Biotech, Inc. pays an indicated annual cash dividend of $ 0.03 per share, with a current dividend yield of 8.07% based on the latest share price. Dividend policies are subject to change at the board's discretion.